Princeton Capital Management LLC Gilead Sciences, Inc. Transaction History

Princeton Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $175,122 - $220,185	-2,820 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $176,616 - $226,220	2,820 New	2,820 $218,000
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $183,381 - $201,713	-2,976 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $8,661 - $9,713	-140 Reduced 4.49%	2,976 $201,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $2,501 - $2,802	-40 Reduced 1.27%	3,116 $203,000

Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $112,907 - $147,335	-1,865 Reduced 37.14%	3,156 $197,000
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $18,231 - $21,266	-281 Reduced 5.3%	5,021 $356,000
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $377,237 - $442,823	5,302	5,302 $380,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.